| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
| mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
| mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.02 |
| mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.02 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |